53 related articles for article (PubMed ID: 36050601)
1. Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Yue Q; Meng L; Jia B; Han W
Exp Ther Med; 2020 Jul; 20(1):436-446. PubMed ID: 32537008
[TBL] [Abstract][Full Text] [Related]
2. Ferulic acid in synergy with retinol alleviates oxidative injury of HaCaT cells during UVB-induced photoaging.
Shu P; Mo J; Li Z; Li M; Zhu W; Du Z
Aging (Albany NY); 2024 Apr; 16(8):7153-7173. PubMed ID: 38643459
[TBL] [Abstract][Full Text] [Related]
3. The Biological Roles of Translation Initiation Factor 3b.
Feng X; Li J; Liu P
Int J Biol Sci; 2018; 14(12):1630-1635. PubMed ID: 30416377
[TBL] [Abstract][Full Text] [Related]
4. Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.
Wei J; Yang Y; Lu M; Xu L; Liu F; Yuan Z; Bao Q; Jiang Z; Xu X; Guo X; Zhang X; You Q; Sun H
Anticancer Agents Med Chem; 2015; 16(2):174-89. PubMed ID: 26343143
[TBL] [Abstract][Full Text] [Related]
5. EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma.
Fang P; Han Y; Qu Y; Wang X; Zhang Y; Zhang W; Zhang N; Li G; Ma W
Cancer Sci; 2022 Dec; 113(12):4181-4192. PubMed ID: 36050601
[TBL] [Abstract][Full Text] [Related]
6. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.
Huang R; Nie W; Mi L; Yao C; Zhu H
Aging (Albany NY); 2024 Apr; 16(8):7311-7330. PubMed ID: 38687509
[TBL] [Abstract][Full Text] [Related]
7. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages increase COX-2 expression promoting endocrine resistance in breast cancer via the PI3K/Akt/mTOR pathway.
Qin Q; Ji H; Li D; Zhang H; Zhang Z; Zhang Q
Neoplasma; 2021 Sep; 68(5):938-946. PubMed ID: 34619972
[TBL] [Abstract][Full Text] [Related]
11. MiR-124-3p Suppresses Prostatic Carcinoma by Targeting PTGS2 Through the AKT/NF-κB Pathway.
Zhang Z
Mol Biotechnol; 2021 Jul; 63(7):621-630. PubMed ID: 33893997
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Xiang P; Sun Y; Fang Z; Yan K; Fan Y
Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
[TBL] [Abstract][Full Text] [Related]
13. Protein Modification and Autophagy Activation.
Wang R; Wang G
Adv Exp Med Biol; 2019; 1206():237-259. PubMed ID: 31776989
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]